Gadeta Revenue and Competitors

Utrecht,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gadeta's estimated annual revenue is currently $4.5M per year.(i)
  • Gadeta's estimated revenue per employee is $155,000

Employee Data

  • Gadeta has 29 Employees.(i)
  • Gadeta grew their employee count by -40% last year.

Gadeta's People

NameTitleEmail/Phone
1
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Gadeta?

Gadeta is a Research & Development company established in 2015 which focusses on the development of innovative immunotherapies for cancer. The work of the company is based on the groundbreaking discoveries regarding the role of γδ T cell receptors (TCRs) in the broad recognition of both hematological and solid tumor cells and their potential use for the treatment of advanced malignancies as discovered by Prof. Dr. Jürgen Kuball, at the University Medical Centre Utrecht (UMCU), The Netherlands.   The Gadeta office and laboratory is located in the Bio Incubator next to the UMCU and collaborates with top-tier international scientists to achieve its goals. 

keywords:N/A

N/A

Total Funding

29

Number of Employees

$4.5M

Revenue (est)

-40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Gadeta News

2022-04-17 - Immunogenicity after second and third mRNA-1273 ...

JBAGH reports consultancy fees from Achilles Therapeutics, BioNTech, BMS, Immunocore, Instil Bio, Molecular Partners, MSD, Gadeta,...

2022-03-22 - Gadeta to Present Data on Tumor-Specific Cell Therapies at Leading Scientific Conferences

UTRECHT, Netherlands and BOSTON, March 28, 2022 /PRNewswire/ -- Gadeta B.V. ('Gadeta'), a clinical-stage company developing innovative,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M29-19%N/A
#2
N/A3036%N/A
#3
$6.1M30-9%N/A
#4
$8.2M317%N/A
#5
$5.2M3115%N/A